Semaglutide Tied to Small Risk of Potentially Blinding Eye Condition

(MedPage Today) -- The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes, according to a retrospective study.
In this review of 37.1 million patients...